As COVID-19 takes a grip on healthcare systems around the world, pharma can take extra measures by putting a stop to in-person physician promotions to reduce traffic across sites of care, says a new blog by ZS s Daniel Brox and Pratap Khedkar . It s time to flip the digital switch, say theOriginal Article
You may also like
FDA Approves SpringWorks Therapeutics Treatment for...
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT:...
Axplora Announces €50 Million Investment in GLP-1...
Drug Digest: Advances in Small-Molecule Manufacturing
Navigating Drug Development: The Critical Role of...
MMS Acquires Exploristics and Its Flagship Modeling...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.